Trial Profile
A German-Austrian, single-arm, open-label, prospective, non-interventional, observational study to evaluate Paricalcitol treatment of secondary hyperparathyroidism in hemodialysis patients
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 28 Nov 2015
Price :
$35
*
At a glance
- Drugs Paricalcitol (Primary)
- Indications Secondary hyperparathyroidism
- Focus Therapeutic Use
- 28 Nov 2015 New trial record